Pragmatic global dosing recommendations for the 3-month, once-weekly rifapentine and isoniazid preventive TB regimen in children

Lignende værker

• Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection
  af: Borisov, Andrey S., et al.
  Udgivet: (2018)
• Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI
  af: Bliven-Sizemore, E. E., et al.
  Udgivet: (2015)
• Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection
  af: Hibma, Jennifer E., et al.
  Udgivet: (2020)
• Effectiveness of Once-Weekly Rifapentine and Moxifloxacin Regimens against Mycobacterium tuberculosis in Mice
  af: Lounis, Nacer, et al.
  Udgivet: (2001)
• Cost‐effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda
  af: Ferguson, Olivia, et al.
  Udgivet: (2020)